A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Clinical trial NCT05452239 · COMPLETED
Trial details
- NCT number
- NCT05452239
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-10-22
- Enrollment
- 608
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.